Clinical Trials Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Oct 21, 2015; 21(39): 11168-11178
Published online Oct 21, 2015. doi: 10.3748/wjg.v21.i39.11168
Figure 3
Figure 3 Association of Wilms’ tumor 1-specific delayed-type hypersensitivity reactions with overall survival. Kaplan-Meier estimates of overall survival (OS) for patients with PDA treated with dendritic cells (DCs) pulsed with Wilms’ tumor 1 (WT1) MHC class I and -II peptides (DC/WT1-I/II) combined with chemotherapy. A: OS in WT1-specific delayed type hypersensitivity (DTH)-positive (n = 4) or -negative (n = 3) responders; B: OS in strongly WT1-specific DTH-positive (n = 3) or -negative (n = 3) responders.